Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trace amine-associated receptor 5 is a member of the trace amine-associated receptor (TAAR) family, one of the class A (rhodopsin-like) G protein-coupled receptors[1][3][7]. TAAR5 is encoded by the *TAAR5* gene and is primarily expressed in the olfactory epithelium of vertebrates, functioning as an olfactory receptor for volatile tertiary amines such as trimethylamine and N,N-dimethylethylamine[7]. It is also expressed in specific brain regions, including the limbic system and cerebellum, where it has been shown to regulate emotional behaviors, postural stability, muscle force, and motor coordination[5][7]. TAAR5 knockout models display altered neurogenesis, dopamine neuron population, and changes in behavioral and sensorimotor profiles. Human genetic variants in TAAR5 influence olfactory perception, particularly sensitivity to fishy odors[7]. Although most TAARs remain orphans, deorphanization efforts have identified several synthetic antagonists and inverse agonists for TAAR5, highlighting its potential as a druggable CNS target for neuropsychiatric, neurodegenerative, and olfactory-perceptual disorders[2][3][8].
Agonists activate TAAR5, primarily modulating olfactory and possibly central nervous system functions. Inverse agonists reduce TAAR5 basal activity. Antagonists inhibit activation by endogenous and exogenous amines, potentially affecting olfactory and CNS signaling.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trace amine-associated receptor 5 (TAAR5).